Hartwig Huland

63.2k total citations · 1 hit paper
613 papers, 17.5k citations indexed

About

Hartwig Huland is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Hartwig Huland has authored 613 papers receiving a total of 17.5k indexed citations (citations by other indexed papers that have themselves been cited), including 430 papers in Pulmonary and Respiratory Medicine, 154 papers in Surgery and 111 papers in Rheumatology. Recurrent topics in Hartwig Huland's work include Prostate Cancer Diagnosis and Treatment (336 papers), Prostate Cancer Treatment and Research (321 papers) and Bladder and Urothelial Cancer Treatments (95 papers). Hartwig Huland is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (336 papers), Prostate Cancer Treatment and Research (321 papers) and Bladder and Urothelial Cancer Treatments (95 papers). Hartwig Huland collaborates with scholars based in Germany, Canada and United States. Hartwig Huland's co-authors include Markus Graefen, Alexander Haese, Thorsten Schlomm, Thomas Steuber, Felix K.‐H. Chun, Andreas Erbersdobler, Hans Heinzer, Pierre I. Karakiewicz, Peter Hammerer and Jochen Walz and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Hartwig Huland

588 papers receiving 17.0k citations

Hit Papers

Initial Experience of 68G... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy
    2015 337 citations Lars Budäus, Sami‐Ramzi Leyh‐Bannurah et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hartwig Huland Germany 73 11.7k 4.2k 3.4k 3.0k 2.8k 613 17.5k
Steven Joniau Belgium 59 14.5k 1.2× 3.4k 0.8× 3.1k 0.9× 3.1k 1.0× 2.9k 1.0× 458 18.7k
Axel Heidenreich Germany 65 14.0k 1.2× 7.2k 1.7× 4.3k 1.2× 3.1k 1.0× 3.6k 1.3× 716 21.5k
Edward M. Messing United States 66 7.8k 0.7× 7.0k 1.7× 1.9k 0.5× 4.0k 1.3× 2.5k 0.9× 380 17.4k
James A. Eastham United States 87 21.8k 1.9× 6.0k 1.4× 6.6k 1.9× 2.3k 0.8× 4.3k 1.5× 538 27.3k
Mitchell C. Benson United States 52 8.6k 0.7× 3.1k 0.7× 1.4k 0.4× 3.9k 1.3× 2.8k 1.0× 268 13.3k
James E. Montie United States 70 10.1k 0.9× 8.2k 2.0× 1.9k 0.6× 4.7k 1.6× 3.9k 1.4× 459 20.8k
Alexandre de la Taille France 68 10.8k 0.9× 3.7k 0.9× 2.4k 0.7× 5.2k 1.7× 1.9k 0.7× 471 15.7k
Alberto Briganti Italy 70 15.5k 1.3× 7.0k 1.7× 4.3k 1.3× 2.2k 0.7× 3.8k 1.4× 1.0k 21.6k
Markus Graefen Germany 81 20.2k 1.7× 6.7k 1.6× 5.7k 1.7× 3.1k 1.0× 3.8k 1.4× 927 26.6k
M. Bolla France 50 16.6k 1.4× 5.1k 1.2× 2.9k 0.8× 1.7k 0.6× 4.6k 1.7× 231 22.9k

Countries citing papers authored by Hartwig Huland

Since Specialization
Citations

This map shows the geographic impact of Hartwig Huland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartwig Huland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartwig Huland more than expected).

Fields of papers citing papers by Hartwig Huland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hartwig Huland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartwig Huland. The network helps show where Hartwig Huland may publish in the future.

Co-authorship network of co-authors of Hartwig Huland

This figure shows the co-authorship network connecting the top 25 collaborators of Hartwig Huland. A scholar is included among the top collaborators of Hartwig Huland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hartwig Huland. Hartwig Huland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tilki, Derya, Anna Suling, Oliver Hahn, et al.. (2021). CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo. Cancer Gene Therapy. 29(1). 49–61. 7 indexed citations
3.
Pompe, Raisa S., Felix Preißer, Sami‐Ramzi Leyh‐Bannurah, et al.. (2020). Association of very low PSA with increased metastases and death in patients with biopsy Gleason score 8-10 prostate cancer. European Urology Open Science. 19. e1892–e1892. 1 indexed citations
4.
Preißer, Felix, Alexander Heinze, Raisa S. Pompe, et al.. (2020). Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with non-organ-confined prostate cancer. European Urology Open Science. 19. e1375–e1375. 1 indexed citations
5.
Quaas, Alexander, Martina Kluth, Corinna Wittmer, et al.. (2016). Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients. BMC Cancer. 16(1). 641–641. 19 indexed citations
6.
Burdelski, Christoph, Claudia Hube‐Magg, Martina Kluth, et al.. (2015). Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer. Clinical Cancer Research. 21(15). 3471–3479. 39 indexed citations
7.
Beyer, Burkhard, et al.. (2015). "Expanded prostate cancer index composite" (EPIC-26): Funktionelles Behandlungsergebnis bei Patienten mit lokalisiertem Prostatakarzinom. 54(11). 1591–1595. 4 indexed citations
8.
9.
Burkhardt, Lia, Antje Krohn, Sawinee Masser, et al.. (2013). CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer. Cancer Research. 73(9). 2795–2805. 130 indexed citations
10.
Bellmunt, Joaquim, Gerhardt Attard, Amit Bahl, et al.. (2012). Advances in the management of high‐risk localised and metastatic prostate cancer. British Journal of Urology. 109(s2). 8–13. 7 indexed citations
11.
Minner, Sarah, Corinna Wittmer, Markus Graefen, et al.. (2010). High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer. The Prostate. 71(3). 281–288. 214 indexed citations
12.
Schlomm, Thorsten, et al.. (2008). Stellenwert der Lymphadenektomie beim Prostatakarzinom. Der Urologe. 48(1). 37–45. 2 indexed citations
13.
Salomon, Georg, Imke Thederan, Felix K.‐H. Chun, et al.. (2008). Evaluation of Prostate Cancer Detection with Ultrasound Real-Time Elastography: A Comparison with Step Section Pathological Analysis after Radical Prostatectomy. European Urology. 54(6). 1354–1362. 194 indexed citations
14.
Ahyai, Sascha, Markus Graefen, Thomas Steuber, et al.. (2007). Contemporary Prostate Cancer Prevalence among T1c Biopsy-Referred Men with a Prostate-Specific Antigen Level ≤ 4.0ng per Milliliter. European Urology. 53(4). 750–757. 22 indexed citations
15.
Giessing, Markus, et al.. (2004). Nierenspende und Nierentransplantation im Alter. Der Urologe. 43(8). 947–54. 4 indexed citations
16.
Steuber, Thomas, Alexander Haese, Kim Pettersson, et al.. (2004). Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue. The Prostate. 63(1). 13–18. 27 indexed citations
17.
Graefen, Markus, Pierre I. Karakiewicz, Ilias Cagiannos, et al.. (2002). A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men. Urologic Oncology Seminars and Original Investigations. 7(4). 141–146. 59 indexed citations
18.
Friedrich, Martin, et al.. (2000). Postoperative Funktionalität und Aspekte zur Lebensqualität nach Penisbegradigung durch die Schröder-Essed-Technik. Der Urologe. 39(5). 440–445. 1 indexed citations
19.
20.
Huland, Hartwig, et al.. (1978). [Can recurrent urinary tracts infections with existing vesicoureteral reflux be checked (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 17(1). 11–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Joniau Breakdown of academic impact, for papers by Axel Heidenreich Breakdown of academic impact, for papers by Edward M. Messing Breakdown of academic impact, for papers by James A. Eastham Breakdown of academic impact, for papers by Mitchell C. Benson Breakdown of academic impact, for papers by James E. Montie Breakdown of academic impact, for papers by Alexandre de la Taille Breakdown of academic impact, for papers by Alberto Briganti Breakdown of academic impact, for papers by Markus Graefen Breakdown of academic impact, for papers by M. Bolla
Rankless by CCL
2026